Диссертация (1146685), страница 19
Текст из файла (страница 19)
– СПб.: Питер, 2001. – 480 с.114105. Цивилько М.А. Динамика психических нарушения у больных с ХПН(терминальная стадия) при оперативном лечении с помощью гемодиализаи пересадки почки: Автореф. дис. док. мед. наук.- М. - 1977.- С.42106. Чернов В. М., Тарасова В. С., Румянцев А. Г. Анемия в практикетерапевта и принципы её коррекции // Лечебное дело. – 2011. – № 1. –С. 81-89.107.
Шило В. Ю. Перспективы лечения анемии у больных хроническойпочечной недостаточностью // Клиницист. – 2006. – № 4. – С. 4-12.108. Шило В. Ю.,Горин А. А.,Денисов А. Ю.,Головкина Т. М.,Сторожаков Г. И. Проблема неподатливости лечению у пациентов напрограммном гемодиализе. Нефрология и диализ.
– 2002. – №1. – С. 4564.109. Шило В. Ю., Денисов А. Ю. Диагностика и лечение нефрогеннойанемии у больных на программном гемодиализе: многолетний опытприменения эпоэтина бета // Клиницист. – 2006. – № 2. – С. 47-53.110. Шишкин А. Н. Лечение диабетической нефропатии на стадии почечнойнедостаточности // Новые Санкт-Петербургские врачебные ведомости. –2008. – № 1. – С. 75-81.111.
Шишкин А. Н. Факторы роста и гломерулосклероз при диабетическойнефропатии // Нефрология. – 2005. – Т. 9, № 4. – С. 104-107.112. Шишкин А. Н.,Гуляев А. Н.,Ферман Р. С.исоавт.ИнфекцияHelicobacter pylori при терминальной стадии хронической болезни почек// Нефрология. – 2007. – Т. 11, № 4.
– С. 59-64.113. Шкловский В.М. Проблемы реабилитации (состояния, перспективы,развития)/В.М.Шкловский//Клиническиеисоциально–психологические аспекты качества жизни психоневрологических больныхв современном обществе: тез. докл. междунар. конф., Санкт-Петербург,9–10 дек. 2003 г. – СПб.: НИПНИ им. В. М. Бехтерева, 2003. – С. 18.115114. ЯнакаеваТ.А.Эмоционально–аффективныенарушенияпридисциркуляторной энцефалопатии и болезни Паркинсона: автореф. дис.канд. мед.наук / Т.А. Янакаева. – М., 1999. – 24 с.115. Яхно Н.Н. Когнитивные и эмоционально–аффективные нарушения придисциркуляторной энцефалопатии / Н.Н.
Яхно, В.В. Захаров //MedLinks.Ru – Раздел: Психиатрия и психология – Опубликовано 18–12–2002.116. Aires I, Matias P, Gil C et al. On-line haemodiafiltration with high volumesubstitution fluid: long-term efficacy and security. Nephrol Dial Transplant. –2007. – Vol 2. – P. 286.117. Allen D, Wainwright M, Hutchinson T. 'Non-compliance' as illnessmanagement: Hemodialysis patients' descriptions of adversarial patientclinician interactions. Soc Sci Med. – 2011 Jul. – Vol 73(1). – P. 129-34118. Alvarez-Lare MA, Martin-Malo A, Esinosa M et al.
Blood pressure andbody water distribution in chronic renal failure patients. Nephrol DialTransplant. – 2001. – Vol 16. – P. 94-97.119. Ameer GA. Modalities for the removal of ß2-microglobulin from blood.Semin Dial. – 2001. – Vol 14. – P. 103-106.120. Anderson K, Devitt J, Cunningham J, Preece C, Jardine M, Cass A. If youcan't comply with dialysis, how do you expect me to trust you withtransplantation? Australian nephrologists' views on indigenous Australians''non-compliance' and their suitability for kidney transplantation. Int J EquityHealth. – 2012. – Vol 18. – P. 11-21121.
Ayli D, Ayli M, Azak M et al. The effect of high-flux hemodialysis on renalanemia. J Nephrol. – 2004. – Vol 17. – P. 701-706.122. Baldamus C, Ernst W, Frei U et al. Sympathetic and hemodynamic responseto volume removal during different forms of renal replacement therapy.Nephron. – 1982. – Vol 31. – P. 324-332.116123. Bammens B, Evenepoel P, Keuleers H et al. Free serum concentrations ofthe protein-bound retention solute p-cresol predict mortality in hemodialysispatients. Kidney Int. – 2006 Mar. – Vol 69(6). – P. 1081-7.124. Bammens B, Evenepoel P, Verbeke K et al. Removal of protein-bounduraemic retention solutes (p-cresol). J Am Soc Nephrol.
– 2003. – Vol 14. –P. 905-911.125. Bautovich A1, Katz I2, Smith M3, Loo CK4, Harvey SB4. Depression andchronic kidney disease: A review for clinicians. Aust N Z J Psychiatry. – 2014Mar 21. – Vol 48(6). – P. 530-541.126. Beddhu S, Bruns FJ., Saul M. et al. A simple comorbidity scale predictsclinical outcomes and costs in dialysis patients. Am J Med. – 2000. – Vol 108.– P.
609-613.127. Bellinghieri G., Santoroi D., Mallamace A. et'al. Sexual dysfunction inchronic renal failure. Nephrology. – 2008. – Vol 21. – P. 113-118.128. Berliner JA, Heinecke JW. The role of oxidised lipoproteins inatherogenesis. Free Radic Biol Med. – 1996. – Vol 20. – P. 707-727.129. Best P J M, Holmes D R. Chronic kidney disease as a cardiovascular riskfactor. American Heart Journal. – 2003. – Vol 145 (3). – P. 383-386.130. Biasioli S, Schiavon R. Homocysteine as a cardiovascular risk factor. BloodPurif. – 2000.
– Vol 18. – P. 177-182.131. Bonforte G, Grillo P, Zerbi S, et al. Improvement of anemia in hemodialysispatients treated by hemodiafiltration with high-volume online- preparedsubstitution fluid. Blood Purif. – 2002. – Vol 20(4). – P. 357-363.132. Bonomini M, Ballone E, Stante S et al. Removal of uraemic plasma factor(s)using different dialysis modalities reduces phosphatidylserine exposure in redblood cells. Nephrol Dial Transplant. – 2004. – Vol 9.
– P. 68-74.133. Bonomini M, Sirolli V, Gizzi F et al. Enhanced adherence of human uremicerythrocytes to vascular endothelium: role of phosphatidylserine exposure.Kidney Int. – 2002. – Vol 62. – P. 1358-1363.117134. Bonomini M, Sirolli V, Settefrati N et al. Increased erythrocytephosphatidylserine exposure in chronic renal failure.
J Am Soc Nephrol. –1999. – Vol 10. – P. 1982-1990.135. Bonomini M, Sirolli V. Uremic toxicity and anemia. J Nephrol. – 2003. –Vol 16. – P. 21-28.136. Bowling A. Measuring Disease: a review of disease–specific quality of lifemeasurement scales / A. Bowling. – Philadelphia: Open University Press. –1996. – 374 p.137. Bowling A. Measuring Health: a review of quality of life measurementscales / A. Bowling. – 2nd ed. – Philadelphia: Open University Press, 1997.
–160 p.138. Canaud B, Bosc JY, Leblanc M et al. Evaluation of high-fluxhemodiafiltration efficiency using an on-line urea monitor. Am J Kidney Dis. –1998. – Vol 31. – P. 74-80.139. Canaud B, Bosc JY, Leray-Moragues H et al. On-line haemodiafiltration.Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant. –2000.
– Vol 15. – P. 60-67.140. Canaud B, Bragg-Gresham JL, Marshall MR, et al. Mortality risk forpatients receiving hemodiafiltration versus hemodialysis: European resultsfrom the DOPPS. Kidney Int. – 2006. – Vol 69(11). – P. 2087-93.141. Canaud B, Bragg-Gresham JL, Marshall MR, et al. Response to ‘Mortalityrisk for patients receiving HDF versus haemodialysis. Kid Int.
– 2006. – Vol70. – P. 1524142. Canaud B, Wizemann V, Pizzarelli F et al. Cellular interleukin-1 receptorantagonist production in patients receive on-line haemodiafiltration therapy.Nephrol Dial Transplant. – 2001. – Vol 16. – P. 2181-2187.143. Carracedo J, Merino A, Nogueras S et al. On-line hemodiafiltration reducesthe proinflammatory CD14+ CD16+ monocyte-derived dendritic cells: aprospective, crossover study. J Am Soc Nephrol. – 2006. – Vol. 4– P. 181-189.118144. Charlson ME., Pompei P., Ales KL. et al. A new method of classifyingprognostic comorbidity in longitudinal studies: development and validation. JChron Dis.
– 1987. – Vol. 40. – P. 373-383.145. Christensen AJ., Wiebe JS., Lawton WJ. Cynical hostility, powerful otherscontrol expectancies, and patient adherence in hemodialysis. Psychosom Med.– 1997 May. – Vol. 59:3. – P. 307-12146. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI,National Kidney Foundation // Am. J. Kidney Dis. – 2000. – Vol. 35. – P. S1–S140.147. Coresh J, Astor B, Sarnak MJ. Evidence for increased cardiovascular diseaserisk in patients with chronic kidney disease. Current Opinion in Nephrologyand Hypertension.
– 2004. – Vol 13. – P. 73-81.148. Cukor D, Coplan J, Brown C, Friedman S, Newville H, Safier M, SpielmanLA, Peterson RA, Kimmel PL. Anxiety disorders in adults treated byhemodialysis: a single-center study. Am J Kidney Dis. – 2008 Jul. – Vol 52(1).– P. 128-36.149. Culleton B F, Hemmelgarn B R. Is chronic kidney disease a cardiovasculardisease risk factor? Seminars in Dialysis. – 2003. – Vol 13 (2). – P.
95-100.150. Dantoine T, Castro R, Leblanc M et al. Popliteal cysts from advancedamyloidosis in long-term haemofiltration/haemodiafiltration. Nephrol DialTransplant. – 1997. – Vol 12. – P. 1512-1515.151. De Jong A. Social disability and outcome in schizophrenic patients / A. DeJong, R. Giel, C.J. Slooff, D. Wiersma // Brit. J. Psychiat. – 1985. – Vol. 147. –N 12. – P. 631–636.152.
DeOreo PB. Hemodialysis patient-assessed functional health status predictscontinued survival, hospitalization, and dialysis-attendance compliance. Am JKidney Dis. – 1997 Aug. – Vol 30:2. – P. 204-12.153. Depasquale C, Pistorio ML, Corona D, Mistretta A, Zerbo D, SinagraN, GiaquintaA, TallaritaT, EskerB, MociskyteD, LeonardiA, GulaR, Veroux P, Veroux M. Correlational study between psychic symptoms and119quality of life among hemodialysis patients older than 55 years of age.Transplant Proc.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
